Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1999 Sep;91(9):497–501.

Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans.

A Gedalia 1, J F Molina 1, J Molina 1, O Uribe 1, C Malagon 1, L R Espinoza 1
PMCID: PMC2608538  PMID: 10517068

Abstract

This study compared the clinical and serologic features in two different ethnic groups of patients with childhood-onset systemic lupus erythematosus (SLE). One hundred seventy-one SLE patients comprised the study population; 61 (55 girls and 6 boys) were African American with age at onset of 13 +/- 2.9 years, and 110 (97 girls and 13 boys) were Latin American (Colombian) with age at onset of 13 +/- 3.2 years. Clinical, demographic, and laboratory data were obtained by chart review using a standard data collection form. African-American patients more commonly manifested discoid skin lesions, malar rash, pulmonary fibrosis, and pleuritis, and less commonly manifested photosensitivity, livedo reticularis, and vascular thrombosis than did Latin Americans. In addition, there was a higher frequency of anti-dsDNA, anti-Sm, anti-RNP, and anti-Ro positivity among African-Americans compared with Latin-American patients. These results suggest the presence of ethnic differences in the clinical expression of SLE.

Full text

PDF
497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adebajo A., Davis P. Rheumatic diseases in African blacks. Semin Arthritis Rheum. 1994 Oct;24(2):139–153. doi: 10.1016/s0049-0172(05)80007-1. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Hamilton R. G., Roebber M. G., Harley J. B., Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol. 1988 Dec;15(12):1773–1776. [PubMed] [Google Scholar]
  3. Ballou S. P., Khan M. A., Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum. 1982 Jan;25(1):55–60. doi: 10.1002/art.1780250109. [DOI] [PubMed] [Google Scholar]
  4. Barron K. S., Silverman E. D., Gonzales J., Reveille J. D. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1993 Mar;36(3):348–354. doi: 10.1002/art.1780360310. [DOI] [PubMed] [Google Scholar]
  5. Citera G., Wilson W. A. Ethnic and geographic perspectives in SLE. Lupus. 1993 Dec;2(6):351–353. doi: 10.1177/096120339300200603. [DOI] [PubMed] [Google Scholar]
  6. Gharavi A. E., Harris E. N., Asherson R. A., Hughes G. R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987 Jan;46(1):1–6. doi: 10.1136/ard.46.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H., Hadler N. M. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982 Jun;25(6):601–611. doi: 10.1002/art.1780250601. [DOI] [PubMed] [Google Scholar]
  8. Gulko P. S., Reveille J. D., Koopman W. J., Burgard S. L., Bartolucci A. A., Alarcón G. S. Survival impact of autoantibodies in systemic lupus erythematosus. J Rheumatol. 1994 Feb;21(2):224–228. [PubMed] [Google Scholar]
  9. Hochberg M. C., Boyd R. E., Ahearn J. M., Arnett F. C., Bias W. B., Provost T. T., Stevens M. B. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985 Sep;64(5):285–295. [PubMed] [Google Scholar]
  10. Oshiro A. C., Derbes S. J., Stopa A. R., Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis. 1997 Apr;56(4):272–274. doi: 10.1136/ard.56.4.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Petri M., Perez-Gutthann S., Longenecker J. C., Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991 Oct;91(4):345–353. doi: 10.1016/0002-9343(91)90151-m. [DOI] [PubMed] [Google Scholar]
  12. Reveille J. D., Bartolucci A., Alarcón G. S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990 Jan;33(1):37–48. doi: 10.1002/art.1780330105. [DOI] [PubMed] [Google Scholar]
  13. Symmons D. P. Frequency of lupus in people of African origin. Lupus. 1995 Jun;4(3):176–178. doi: 10.1177/096120339500400303. [DOI] [PubMed] [Google Scholar]
  14. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  15. Ward M. M., Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med. 1990 Apr;150(4):849–853. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES